Alison Bauer
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinogenesis | 5 | 2020 | 217 | 1.900 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 5 | 2021 | 29 | 1.840 |
Why?
| | Lung Neoplasms | 16 | 2024 | 2526 | 1.640 |
Why?
| | Pneumonia | 9 | 2025 | 639 | 1.550 |
Why?
| | Butylated Hydroxytoluene | 9 | 2020 | 38 | 1.330 |
Why?
| | Lung | 13 | 2025 | 4060 | 1.250 |
Why?
| | Carcinogens | 5 | 2017 | 125 | 1.220 |
Why?
| | Toll-Like Receptor 4 | 4 | 2016 | 273 | 1.210 |
Why?
| | Mast Cells | 3 | 2025 | 147 | 1.020 |
Why?
| | Formaldehyde | 1 | 2025 | 63 | 0.920 |
Why?
| | Anthracenes | 4 | 2023 | 31 | 0.920 |
Why?
| | Ozone | 6 | 2011 | 132 | 0.870 |
Why?
| | Lightning | 1 | 2023 | 2 | 0.830 |
Why?
| | Lightning Injuries | 1 | 2023 | 4 | 0.820 |
Why?
| | Mice, Inbred BALB C | 10 | 2020 | 1272 | 0.810 |
Why?
| | Signal Transduction | 6 | 2019 | 5079 | 0.790 |
Why?
| | Methylcholanthrene | 3 | 2020 | 22 | 0.780 |
Why?
| | Inflammation Mediators | 1 | 2025 | 513 | 0.750 |
Why?
| | Fluorenes | 2 | 2019 | 44 | 0.740 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2013 | 93 | 0.730 |
Why?
| | Sports | 1 | 2023 | 231 | 0.660 |
Why?
| | Genetic Predisposition to Disease | 8 | 2010 | 2426 | 0.640 |
Why?
| | Eicosanoids | 1 | 2019 | 62 | 0.610 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 114 | 0.570 |
Why?
| | Mucin 5AC | 1 | 2018 | 70 | 0.570 |
Why?
| | Mice | 29 | 2025 | 17787 | 0.570 |
Why?
| | Mitogens | 1 | 2017 | 61 | 0.540 |
Why?
| | Animals | 34 | 2025 | 36940 | 0.530 |
Why?
| | Inflammation | 6 | 2017 | 2837 | 0.530 |
Why?
| | Air Pollutants | 4 | 2020 | 430 | 0.520 |
Why?
| | Benzene | 4 | 2005 | 18 | 0.520 |
Why?
| | Epiregulin | 1 | 2016 | 2 | 0.510 |
Why?
| | Military Personnel | 1 | 2023 | 544 | 0.500 |
Why?
| | Acetylcysteine | 1 | 2016 | 145 | 0.470 |
Why?
| | Lung Diseases | 4 | 2017 | 767 | 0.470 |
Why?
| | Pulmonary Alveoli | 1 | 2017 | 405 | 0.460 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 261 | 0.440 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 1081 | 0.440 |
Why?
| | Adenocarcinoma | 3 | 2016 | 940 | 0.440 |
Why?
| | Gene Deletion | 2 | 2016 | 391 | 0.440 |
Why?
| | Nanotubes, Carbon | 3 | 2020 | 47 | 0.420 |
Why?
| | Epithelial Cells | 6 | 2020 | 1096 | 0.420 |
Why?
| | Gap Junctions | 4 | 2020 | 59 | 0.400 |
Why?
| | Urethane | 3 | 2011 | 43 | 0.390 |
Why?
| | Mitogen-Activated Protein Kinases | 4 | 2020 | 313 | 0.380 |
Why?
| | Connexin 43 | 3 | 2017 | 32 | 0.370 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2016 | 1396 | 0.370 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1774 | 0.370 |
Why?
| | Ethanol | 1 | 2016 | 608 | 0.360 |
Why?
| | Cell Communication | 3 | 2020 | 315 | 0.350 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 73 | 0.350 |
Why?
| | Enzyme Activation | 3 | 2019 | 810 | 0.340 |
Why?
| | Cell Line | 5 | 2020 | 2847 | 0.340 |
Why?
| | Vanadium Compounds | 1 | 2010 | 1 | 0.340 |
Why?
| | Immunity, Innate | 1 | 2016 | 828 | 0.330 |
Why?
| | Lung Injury | 2 | 2010 | 219 | 0.310 |
Why?
| | Oxidative Stress | 1 | 2016 | 1317 | 0.310 |
Why?
| | Bronchoalveolar Lavage Fluid | 4 | 2025 | 652 | 0.300 |
Why?
| | Cyclooxygenase 2 | 2 | 2019 | 178 | 0.280 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2019 | 2057 | 0.260 |
Why?
| | Air Pollution | 1 | 2010 | 316 | 0.260 |
Why?
| | Molecular Weight | 2 | 2019 | 335 | 0.250 |
Why?
| | Hematologic Diseases | 2 | 2003 | 62 | 0.250 |
Why?
| | Bone Marrow Cells | 3 | 2003 | 316 | 0.240 |
Why?
| | Unnecessary Procedures | 1 | 2024 | 50 | 0.220 |
Why?
| | Quantitative Trait, Heritable | 2 | 2002 | 125 | 0.220 |
Why?
| | Epoxide Hydrolases | 2 | 2005 | 13 | 0.220 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2005 | 32 | 0.220 |
Why?
| | Brain | 1 | 2016 | 2668 | 0.220 |
Why?
| | DNA Damage | 3 | 2020 | 420 | 0.210 |
Why?
| | Precancerous Conditions | 1 | 2024 | 169 | 0.200 |
Why?
| | Mutation | 4 | 2018 | 3958 | 0.200 |
Why?
| | Organophosphonates | 1 | 2023 | 93 | 0.190 |
Why?
| | Occupational Injuries | 1 | 2023 | 44 | 0.190 |
Why?
| | Chemokines | 2 | 2016 | 228 | 0.190 |
Why?
| | Preoperative Care | 1 | 2024 | 362 | 0.190 |
Why?
| | Mice, Inbred Strains | 5 | 2014 | 409 | 0.190 |
Why?
| | Saccharum | 1 | 2023 | 77 | 0.190 |
Why?
| | Phosphorylation | 2 | 2019 | 1759 | 0.190 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5757 | 0.190 |
Why?
| | Heat Stress Disorders | 1 | 2023 | 76 | 0.180 |
Why?
| | Dendritic Cells | 1 | 2025 | 483 | 0.180 |
Why?
| | Chromosome Mapping | 2 | 2002 | 523 | 0.180 |
Why?
| | Time Factors | 3 | 2019 | 6828 | 0.180 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.180 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.180 |
Why?
| | Nanofibers | 1 | 2020 | 21 | 0.170 |
Why?
| | Macrophages | 2 | 2021 | 1547 | 0.170 |
Why?
| | Hot Temperature | 2 | 2023 | 391 | 0.170 |
Why?
| | Male | 15 | 2025 | 67762 | 0.170 |
Why?
| | Cell Movement | 1 | 2025 | 967 | 0.170 |
Why?
| | Mustard Gas | 1 | 2021 | 103 | 0.170 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 114 | 0.160 |
Why?
| | Printing | 1 | 2019 | 5 | 0.160 |
Why?
| | Paper | 1 | 2019 | 10 | 0.160 |
Why?
| | Electrocardiography | 1 | 2023 | 629 | 0.160 |
Why?
| | Athletes | 1 | 2023 | 423 | 0.150 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 47 | 0.150 |
Why?
| | Occupational Exposure | 1 | 2023 | 341 | 0.150 |
Why?
| | Bronchi | 1 | 2020 | 260 | 0.150 |
Why?
| | Nitrogen | 1 | 2019 | 168 | 0.150 |
Why?
| | Cell Degranulation | 1 | 2018 | 41 | 0.140 |
Why?
| | Particulate Matter | 2 | 2019 | 315 | 0.140 |
Why?
| | Inhalation Exposure | 3 | 2020 | 105 | 0.140 |
Why?
| | Cytochrome P-450 CYP1B1 | 1 | 2017 | 5 | 0.140 |
Why?
| | DNA Adducts | 1 | 2017 | 17 | 0.140 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 283 | 0.140 |
Why?
| | Benzo(a)pyrene | 1 | 2017 | 8 | 0.140 |
Why?
| | Monocytes | 1 | 2021 | 563 | 0.140 |
Why?
| | Silver | 1 | 2018 | 38 | 0.140 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 176 | 0.140 |
Why?
| | Survival Analysis | 2 | 2018 | 1325 | 0.140 |
Why?
| | Air Pollution, Indoor | 1 | 2019 | 180 | 0.130 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 267 | 0.130 |
Why?
| | Algorithms | 1 | 2024 | 1704 | 0.130 |
Why?
| | Humans | 17 | 2024 | 137585 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2024 | 1069 | 0.130 |
Why?
| | Environmental Monitoring | 1 | 2019 | 370 | 0.130 |
Why?
| | Lipid Peroxides | 1 | 2016 | 10 | 0.130 |
Why?
| | Glutathione Peroxidase | 1 | 2016 | 43 | 0.130 |
Why?
| | Chick Embryo | 1 | 2016 | 130 | 0.130 |
Why?
| | Up-Regulation | 1 | 2019 | 843 | 0.120 |
Why?
| | Bronchoalveolar Lavage | 1 | 2016 | 93 | 0.120 |
Why?
| | Brain Chemistry | 1 | 2016 | 117 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 99 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 976 | 0.120 |
Why?
| | ErbB Receptors | 1 | 2018 | 614 | 0.120 |
Why?
| | Environment | 1 | 2017 | 358 | 0.110 |
Why?
| | Climate Change | 1 | 2017 | 183 | 0.110 |
Why?
| | Allergens | 1 | 2018 | 409 | 0.110 |
Why?
| | Glutathione | 1 | 2016 | 356 | 0.110 |
Why?
| | Particle Size | 3 | 2020 | 394 | 0.110 |
Why?
| | Withania | 1 | 2014 | 6 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2010 | 4295 | 0.110 |
Why?
| | Heart Diseases | 1 | 2017 | 346 | 0.100 |
Why?
| | Metabolomics | 1 | 2019 | 678 | 0.100 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 1 | 2013 | 12 | 0.100 |
Why?
| | Inactivation, Metabolic | 2 | 2003 | 11 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2021 | 1991 | 0.100 |
Why?
| | Fatty Acids | 1 | 2016 | 443 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2167 | 0.100 |
Why?
| | Blood-Brain Barrier | 1 | 2014 | 138 | 0.100 |
Why?
| | Genomics | 1 | 2018 | 795 | 0.100 |
Why?
| | Cell Membrane | 1 | 2016 | 738 | 0.100 |
Why?
| | Mice, Inbred A | 2 | 2010 | 49 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2017 | 579 | 0.090 |
Why?
| | Plant Extracts | 1 | 2014 | 202 | 0.090 |
Why?
| | Cell Death | 1 | 2013 | 374 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1276 | 0.090 |
Why?
| | Gene Expression | 1 | 2016 | 1502 | 0.090 |
Why?
| | Species Specificity | 2 | 2010 | 585 | 0.090 |
Why?
| | Transcriptome | 1 | 2017 | 971 | 0.090 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2011 | 99 | 0.080 |
Why?
| | Genes, Neoplasm | 1 | 2009 | 22 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 455 | 0.080 |
Why?
| | Prognosis | 1 | 2018 | 4030 | 0.080 |
Why?
| | Disease Progression | 2 | 2024 | 2757 | 0.080 |
Why?
| | Transcription Factor AP-1 | 2 | 2007 | 92 | 0.080 |
Why?
| | Surface Properties | 2 | 2020 | 413 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 852 | 0.070 |
Why?
| | Interleukin-10 | 1 | 2010 | 302 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2607 | 0.070 |
Why?
| | Antineoplastic Agents | 2 | 2013 | 2129 | 0.070 |
Why?
| | Scavenger Receptors, Class A | 1 | 2007 | 12 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 1 | 2013 | 916 | 0.070 |
Why?
| | Micronucleus Tests | 2 | 2005 | 6 | 0.070 |
Why?
| | Oxidants | 1 | 2007 | 111 | 0.060 |
Why?
| | Cell Survival | 2 | 2020 | 1120 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 2 | 2003 | 31 | 0.060 |
Why?
| | Macrophages, Alveolar | 2 | 2007 | 391 | 0.060 |
Why?
| | Microsomes, Liver | 2 | 2003 | 86 | 0.060 |
Why?
| | Cyclins | 2 | 2003 | 91 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2003 | 121 | 0.060 |
Why?
| | Nitric Oxide Synthase | 2 | 2005 | 240 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2007 | 216 | 0.060 |
Why?
| | Neoplasm Staging | 1 | 2009 | 1389 | 0.060 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3412 | 0.060 |
Why?
| | Cytokines | 2 | 2021 | 2085 | 0.060 |
Why?
| | NF-kappa B | 2 | 2007 | 691 | 0.060 |
Why?
| | Prostaglandins | 1 | 2005 | 97 | 0.060 |
Why?
| | Female | 5 | 2024 | 73304 | 0.060 |
Why?
| | Mice, Knockout | 4 | 2007 | 3015 | 0.060 |
Why?
| | RNA, Messenger | 4 | 2010 | 2833 | 0.060 |
Why?
| | Administration, Inhalation | 2 | 2003 | 688 | 0.060 |
Why?
| | Bone Marrow | 1 | 2005 | 286 | 0.050 |
Why?
| | Mutagens | 1 | 2003 | 22 | 0.050 |
Why?
| | Chronic Disease | 1 | 2009 | 1793 | 0.050 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2003 | 60 | 0.050 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2005 | 327 | 0.050 |
Why?
| | Nitric Oxide | 2 | 2005 | 915 | 0.050 |
Why?
| | Lod Score | 1 | 2002 | 67 | 0.050 |
Why?
| | Models, Biological | 1 | 2009 | 1783 | 0.050 |
Why?
| | Anticarcinogenic Agents | 1 | 2002 | 77 | 0.050 |
Why?
| | Transcription Factors | 1 | 2010 | 1719 | 0.050 |
Why?
| | Hematopoietic Stem Cells | 1 | 2005 | 406 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1242 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3284 | 0.050 |
Why?
| | Leukocytes | 1 | 2003 | 311 | 0.040 |
Why?
| | Mechlorethamine | 1 | 2021 | 60 | 0.040 |
Why?
| | Decision Support Systems, Clinical | 1 | 2024 | 226 | 0.040 |
Why?
| | Genetic Markers | 1 | 2002 | 344 | 0.040 |
Why?
| | Societies, Medical | 1 | 2024 | 820 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 679 | 0.040 |
Why?
| | Graphite | 1 | 2019 | 13 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 350 | 0.040 |
Why?
| | Sulfonamides | 1 | 2002 | 513 | 0.040 |
Why?
| | Dinitrobenzenes | 1 | 2018 | 5 | 0.040 |
Why?
| | Metals | 1 | 2019 | 136 | 0.040 |
Why?
| | Receptors, IgE | 1 | 2018 | 45 | 0.040 |
Why?
| | Genetic Variation | 1 | 2003 | 991 | 0.040 |
Why?
| | Metal Nanoparticles | 1 | 2018 | 83 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 672 | 0.030 |
Why?
| | Sex Factors | 1 | 2003 | 2071 | 0.030 |
Why?
| | Cell Cycle | 1 | 2019 | 601 | 0.030 |
Why?
| | DNA | 1 | 2003 | 1459 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 324 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1502 | 0.030 |
Why?
| | United States | 2 | 2024 | 14841 | 0.030 |
Why?
| | Disaccharides | 1 | 2014 | 19 | 0.030 |
Why?
| | Microscopy, Polarization | 1 | 2014 | 31 | 0.030 |
Why?
| | Global Health | 1 | 2017 | 386 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2014 | 107 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2005 | 173 | 0.030 |
Why?
| | Mesothelioma | 1 | 2014 | 44 | 0.030 |
Why?
| | Hyperplasia | 1 | 2014 | 175 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2021 | 4193 | 0.030 |
Why?
| | Fruit | 1 | 2014 | 140 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2014 | 390 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 597 | 0.020 |
Why?
| | Adenoma | 1 | 2014 | 230 | 0.020 |
Why?
| | B7-2 Antigen | 1 | 2010 | 27 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2010 | 43 | 0.020 |
Why?
| | Indoles | 1 | 2014 | 412 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2014 | 739 | 0.020 |
Why?
| | Coal Ash | 1 | 2007 | 8 | 0.020 |
Why?
| | TNF Receptor-Associated Factor 2 | 1 | 2007 | 8 | 0.020 |
Why?
| | Epoxy Compounds | 1 | 2007 | 33 | 0.020 |
Why?
| | Inhalation | 1 | 2007 | 29 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 298 | 0.020 |
Why?
| | Carbon | 1 | 2007 | 216 | 0.010 |
Why?
| | Reticulocytes | 1 | 2005 | 18 | 0.010 |
Why?
| | Aged | 1 | 2024 | 23961 | 0.010 |
Why?
| | Micronuclei, Chromosome-Defective | 1 | 2003 | 7 | 0.010 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2003 | 17 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2007 | 518 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2007 | 1060 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 33479 | 0.010 |
Why?
| | Homozygote | 1 | 2003 | 203 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 79 | 0.010 |
Why?
| | Celecoxib | 1 | 2002 | 39 | 0.010 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 64 | 0.010 |
Why?
| | Lymphokines | 1 | 2002 | 131 | 0.010 |
Why?
| | Neutrophils | 1 | 2007 | 1238 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2002 | 382 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 545 | 0.010 |
Why?
| | Pyrazoles | 1 | 2002 | 423 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 712 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1738 | 0.010 |
Why?
| | Erythrocytes | 1 | 2003 | 700 | 0.010 |
Why?
| | Apoptosis | 1 | 2003 | 2553 | 0.010 |
Why?
|
|
Bauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|